Patients with chronic kidney disease have downregulation of the expression of hepatic apolipoprotein A-I and lecithin cholesterol acyltransferase, which results in impaired high-density lipoprotein-mediated cholesterol uptake from vascular tissue [29]. Here, LCAT is linked to chronic kidney disease.